PE20091160A1 - Recubrimiento de tabletas farmaceuticas y/o nutraceuticas y/o veterinarias - Google Patents

Recubrimiento de tabletas farmaceuticas y/o nutraceuticas y/o veterinarias

Info

Publication number
PE20091160A1
PE20091160A1 PE2008001869A PE2008001869A PE20091160A1 PE 20091160 A1 PE20091160 A1 PE 20091160A1 PE 2008001869 A PE2008001869 A PE 2008001869A PE 2008001869 A PE2008001869 A PE 2008001869A PE 20091160 A1 PE20091160 A1 PE 20091160A1
Authority
PE
Peru
Prior art keywords
oil
pharmaceutical
flavor
coating
plastifier
Prior art date
Application number
PE2008001869A
Other languages
English (en)
Spanish (es)
Inventor
David John Willoughby
Original Assignee
Mcp Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40535662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091160(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2007906008A external-priority patent/AU2007906008A0/en
Application filed by Mcp Operations Pty Ltd filed Critical Mcp Operations Pty Ltd
Publication of PE20091160A1 publication Critical patent/PE20091160A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2008001869A 2007-11-01 2008-10-31 Recubrimiento de tabletas farmaceuticas y/o nutraceuticas y/o veterinarias PE20091160A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2007906008A AU2007906008A0 (en) 2007-11-01 Improved tablet coating

Publications (1)

Publication Number Publication Date
PE20091160A1 true PE20091160A1 (es) 2009-08-06

Family

ID=40535662

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001869A PE20091160A1 (es) 2007-11-01 2008-10-31 Recubrimiento de tabletas farmaceuticas y/o nutraceuticas y/o veterinarias

Country Status (18)

Country Link
US (1) US20100266687A1 (https=)
EP (1) EP2217218A4 (https=)
JP (1) JP2011502132A (https=)
KR (1) KR20100098612A (https=)
CN (1) CN101842087A (https=)
AR (1) AR069158A1 (https=)
AU (1) AU2008318270A1 (https=)
CA (1) CA2704102A1 (https=)
CL (1) CL2008003230A1 (https=)
IL (1) IL205200A0 (https=)
MX (1) MX2010004772A (https=)
NZ (1) NZ584764A (https=)
PA (1) PA8802901A1 (https=)
PE (1) PE20091160A1 (https=)
RU (1) RU2010122062A (https=)
TW (1) TW200927198A (https=)
UY (1) UY31452A1 (https=)
WO (1) WO2009055846A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1404366B1 (it) * 2009-07-17 2013-11-22 Norgine Bv Composizioni perfezionate per la pulizia del colon
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
MX357636B (es) * 2011-02-14 2018-07-17 Procter & Gamble Formas de dosificacion solidas que comprenden miel en el recubrimiento.
WO2013172297A1 (ja) * 2012-05-14 2013-11-21 塩野義製薬株式会社 ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有製剤
US20140099426A1 (en) * 2012-10-10 2014-04-10 Pharmavite Llc Natural coating formulas and composition for coating tablets
WO2014203819A1 (ja) * 2013-06-17 2014-12-24 日本曹達株式会社 ヒドロキシアルキルセルロースを含有するコーティング剤
JP6196730B2 (ja) * 2014-03-31 2017-09-13 富山化学工業株式会社 セファロスポリンエステルを含む粒状固形製剤およびその製造方法
KR102329377B1 (ko) 2017-02-03 2021-11-19 가부시키가이샤 도요 신야쿠 고형 제제
CN110157516B (zh) * 2019-06-27 2021-11-23 合肥工业大学 纳米二氧化钛/黑磷纳米片复合润滑剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3165438B2 (ja) * 1990-04-04 2001-05-14 バーウィンド・ファーマス―ティカル・サーヴィスィーズ・インコーポレーテッド 水性のマルトデキストリン及びセルロースポリマーフィルムコーティング
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
EP0996508B1 (en) * 1997-01-06 2004-08-11 BPSI Holdings, Inc. Film coatings and film coating compositions based on dextrin
US6660302B1 (en) * 2000-09-06 2003-12-09 Chr. Hansen, Inc. Dry-powder film coating composition and method of preparation
US20030082231A1 (en) * 2001-02-02 2003-05-01 Cheryl Kos Coating for orally administered compositions
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US6656493B2 (en) * 2001-07-30 2003-12-02 Wm. Wrigley Jr. Company Edible film formulations containing maltodextrin
US20030026826A1 (en) * 2001-07-31 2003-02-06 Cherukuri Subraman Rao Sugar-free chewy products and protein-based chewy products and methods for making the same
WO2003084511A1 (en) * 2002-04-04 2003-10-16 Pfizer Products Inc. Palatable chewable tablet
US20060246174A1 (en) * 2002-09-24 2006-11-02 Lone Andersen Gum base
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose

Also Published As

Publication number Publication date
AR069158A1 (es) 2009-12-30
AU2008318270A1 (en) 2009-05-07
TW200927198A (en) 2009-07-01
CA2704102A1 (en) 2009-05-07
EP2217218A1 (en) 2010-08-18
MX2010004772A (es) 2010-06-25
PA8802901A1 (es) 2009-07-23
CN101842087A (zh) 2010-09-22
EP2217218A4 (en) 2013-01-09
CL2008003230A1 (es) 2009-11-27
KR20100098612A (ko) 2010-09-08
IL205200A0 (en) 2010-12-30
JP2011502132A (ja) 2011-01-20
UY31452A1 (es) 2009-03-31
NZ584764A (en) 2012-04-27
RU2010122062A (ru) 2011-12-10
WO2009055846A1 (en) 2009-05-07
US20100266687A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
PE20091160A1 (es) Recubrimiento de tabletas farmaceuticas y/o nutraceuticas y/o veterinarias
CR20110278A (es) Cartucho, un dispensador de medicamentos para porciones de medicamentos sólidos y el uso del cartucho y del dispensador de medicamentos
PE20061449A1 (es) Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion
CL2011000935A1 (es) Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor.
EA200700340A1 (ru) Мультичастицы
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
CO6210806A2 (es) Composiciones con forma de dosificacion simple para liberar multiples farmacos a diferentes velocidades de liberacion
MX2009010289A (es) Composiciones para administracion nasal.
MX337657B (es) Composicion no espumante para el cuidado personal en forma de un articulo.
EP1992676A4 (en) ORGANOMOLYBDEN ADDITIVE, PREPARATION THEREOF, AND LUBRICANT COMPOSITION CONTAINING THE ADDITIVE, AND USES THEREOF
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
ECSP11011078A (es) Agente de sostén
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
BR112012024139A2 (pt) formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
ECSP099320A (es) Compuestos de tetrahidropirrolopiracina sustituida y su aplicación en medicamentos
CL2007003154A1 (es) Compuestos derivados de pirazolina; composicion farmaceutica que comprende a los compuestos; y uso para tratar afecciones cardiovasculares, renales, hepaticas y vasculares entre otras.
AR069563A1 (es) Composicion para el cuidado personal que comprende una mezcla eutetica con un agente anticaspa a base de ketoconasol
CL2007001270A1 (es) Metodo de control de enfermedades de plantas mendiante el uso de una composicion que comprende clorotalonilo en particulas solidas de entre 0,1 a 0,3 micrones.
AR079122A1 (es) Composicion de revestimiento por extrusion
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
CR11398A (es) Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo.
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
AR074765A1 (es) Esmalte de unas que comprende un aceite secante, un polimero formador de pelicula, y una sal metalica, y producto para maquillar
UY31887A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión

Legal Events

Date Code Title Description
FC Refusal